178 related articles for article (PubMed ID: 29219254)
21. Uveal Melanoma Risk Factors: A Systematic Review of Meta-Analyses.
Nayman T; Bostan C; Logan P; Burnier MN
Curr Eye Res; 2017 Aug; 42(8):1085-1093. PubMed ID: 28494168
[TBL] [Abstract][Full Text] [Related]
22. Clinical, pathologic, and imaging features and biological markers of uveal melanoma.
Rashid AB; Grossniklaus HE
Methods Mol Biol; 2014; 1102():397-425. PubMed ID: 24258990
[TBL] [Abstract][Full Text] [Related]
23. Non-ocular primary malignancies in patients with uveal melanoma: the Liverpool experience.
Heussen FM; Coupland SE; Kalirai H; Damato BE; Heimann H
Br J Ophthalmol; 2016 Mar; 100(3):356-9. PubMed ID: 26178903
[TBL] [Abstract][Full Text] [Related]
24. Second Primary Neoplasms in Patients With Uveal Melanoma: A SEER Database Analysis.
Laíns I; Bartosch C; Mondim V; Healy B; Kim IK; Husain D; Miller JW
Am J Ophthalmol; 2016 May; 165():54-64. PubMed ID: 26940164
[TBL] [Abstract][Full Text] [Related]
25. Uveal melanoma: A pathologist's perspective and review of translational developments.
Schoenfield L
Adv Anat Pathol; 2014 Mar; 21(2):138-43. PubMed ID: 24508696
[TBL] [Abstract][Full Text] [Related]
26. Uveal melanoma: estimating prognosis.
Kaliki S; Shields CL; Shields JA
Indian J Ophthalmol; 2015 Feb; 63(2):93-102. PubMed ID: 25827538
[TBL] [Abstract][Full Text] [Related]
27. Uveal melanoma in Israel in the last two decades: characterization, treatment and prognosis.
Frenkel S; Hendler K; Pe'er J
Isr Med Assoc J; 2009 May; 11(5):280-5. PubMed ID: 19637505
[TBL] [Abstract][Full Text] [Related]
28. Surgery vs. radiotherapy in patients with uveal melanoma : Analysis of the SEER database using propensity score matching and weighting.
Jang BS; Chang JH; Oh S; Lim YJ; Kim IH
Strahlenther Onkol; 2017 Nov; 193(11):931-942. PubMed ID: 28879443
[TBL] [Abstract][Full Text] [Related]
29. Uveal melanoma.
Jager MJ; Shields CL; Cebulla CM; Abdel-Rahman MH; Grossniklaus HE; Stern MH; Carvajal RD; Belfort RN; Jia R; Shields JA; Damato BE
Nat Rev Dis Primers; 2020 Apr; 6(1):24. PubMed ID: 32273508
[TBL] [Abstract][Full Text] [Related]
30. Additional primary malignancies in a Polish cohort of uveal melanoma patients: a review of 644 patients with long-term follow-up.
Wróblewska-Zierhoffer M; Paprzycka B; Kubiak A; Tomczyk Ł; Rospond-Kubiak I
BMC Ophthalmol; 2023 Dec; 23(1):506. PubMed ID: 38087265
[TBL] [Abstract][Full Text] [Related]
31. Ocular melanoma-when you have seen one, you have not seen them all: a clinical outcome study from the Surveillance, Epidemiology and End Results (SEER) database (1973-2012).
Mahendraraj K; Shrestha S; Lau CS; Chamberlain RS
Clin Ophthalmol; 2017; 11():153-160. PubMed ID: 28115829
[TBL] [Abstract][Full Text] [Related]
32. Clinical Characteristics of Uveal Melanoma in Patients With Germline BAP1 Mutations.
Gupta MP; Lane AM; DeAngelis MM; Mayne K; Crabtree M; Gragoudas ES; Kim IK
JAMA Ophthalmol; 2015 Aug; 133(8):881-7. PubMed ID: 25974357
[TBL] [Abstract][Full Text] [Related]
33. Uveal melanoma among Finnish children and young adults.
Al-Jamal RT; Kivelä T
J AAPOS; 2014 Feb; 18(1):61-6. PubMed ID: 24568985
[TBL] [Abstract][Full Text] [Related]
34. Endoresection with adjuvant ruthenium brachytherapy for selected uveal melanoma patients - the Tuebingen experience.
Süsskind D; Dürr C; Paulsen F; Kaulich T; Bartz-Schmidt KU
Acta Ophthalmol; 2017 Dec; 95(8):e727-e733. PubMed ID: 27914117
[TBL] [Abstract][Full Text] [Related]
35. Digital PCR validates 8q dosage as prognostic tool in uveal melanoma.
Versluis M; de Lange MJ; van Pelt SI; Ruivenkamp CA; Kroes WG; Cao J; Jager MJ; Luyten GP; van der Velden PA
PLoS One; 2015; 10(3):e0116371. PubMed ID: 25764247
[TBL] [Abstract][Full Text] [Related]
36. SOX10 Expression as Well as BRAF and GNAQ/11 Mutations Distinguish Pigmented Ciliary Epithelium Neoplasms From Uveal Melanomas.
Mori T; Sukeda A; Sekine S; Shibata S; Ryo E; Okano H; Suzuki S; Hiraoka N
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5445-5451. PubMed ID: 29059311
[TBL] [Abstract][Full Text] [Related]
37. Unique Geospatial Accumulations of Uveal Melanoma.
Orloff M; Brennan M; Sato S; Shields CL; Shields JA; Lally S; Mashayekhi A; Mason J; Materin M; Mastrangelo M; Sato T
Am J Ophthalmol; 2020 Dec; 220():102-109. PubMed ID: 32681908
[TBL] [Abstract][Full Text] [Related]
38. Genetic prognostication in uveal melanoma.
Dogrusöz M; Jager MJ
Acta Ophthalmol; 2018 Jun; 96(4):331-347. PubMed ID: 29105334
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant Sunitinib in High-Risk Patients with Uveal Melanoma: Comparison with Institutional Controls.
Valsecchi ME; Orloff M; Sato R; Chervoneva I; Shields CL; Shields JA; Mastrangelo MJ; Sato T
Ophthalmology; 2018 Feb; 125(2):210-217. PubMed ID: 28935400
[TBL] [Abstract][Full Text] [Related]
40. Additional malignancies and mortality in uveal melanoma: A 20-year follow-up of a Norwegian patient cohort.
Robsahm TE; Falk RS; Eide NA
Acta Ophthalmol; 2023 Sep; 101(6):696-704. PubMed ID: 36924309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]